Earnings Feed
Start Free
Home/Filings/4/0001179110-13-007427
4//SEC Filing

Smith Scott E 4

Accession 0001179110-13-007427

CIK 0001222244other
View on SEC.govCompany Profile

Filed

Apr 29, 8:00 PM ET

Accepted

Apr 30, 9:36 PM ET

Size

18.7 KB

Accession

0001179110-13-007427

Insider Transaction Report

Form 4
Period: 2013-04-25
ProUroCare Medical Inc.PUMD
Smith Scott E
Director
Transactions
  • Award

    Warrant

    2013-04-25$5500.00/sh+33,000$181,500,000→ 33,000 total
    Exercise: $0.50Exp: 2018-04-25→ Common Stock, $0.00001 par value (33,000 underlying)
Holdings

  • Warrants

    Exercise: $1.30Exp: 2014-01-07→ Common stock, $0.00001 par value (10,000 underlying)
    10,000

  • Warrants

    Exercise: $1.30Exp: 2013-07-12→ Common stock, $0.00001 par value (32,475 underlying)
    32,475

  • Options

    Exercise: $1.72Exp: 2017-08-10→ Common stock $0.00001 par value (14,535 underlying)
    14,535

  • Stock options

    Exercise: $0.87Exp: 2018-08-09→ Common stock, $0.00001 par value (28,736 underlying)
    28,736

  • Stock Options

    Exercise: $0.60Exp: 2019-08-09→ Common stock, $0.00001 par value (25,000 underlying)
    25,000

  • Stock Options

    Exercise: $7.00Exp: 2013-05-30→ Common Stock, $0.00001 par value (3,000 underlying)
    3,000

  • Stock Options

    Exercise: $1.00Exp: 2015-08-12→ Common stock, $0.00001 par value (1,000 underlying)
    1,000

  • Stock Options

    Exercise: $0.85Exp: 2016-03-03→ Common stock, $0.00001 par value (20,000 underlying)
    20,000

  • Stock Options

    Exercise: $1.25Exp: 2016-08-11→ Common Stock, $0.00001 par value (1,000 underlying)
    1,000

  • Stock options

    Exercise: $1.50Exp: 2016-09-29→ Common stock, $0.00001 par value (30,000 underlying)
    30,000

  • Common Stock, $0.00001 par value

    196,193
Footnotes (3)
  • [F1]Currently exercisable.
  • [F2]Annual option award pursuant to the Issuer's compensation policy for Directors upon their re-election to the Board of Directors. The seven-year options vest ratably over the 12 month period from September 2012 to Auguat 2013.
  • [F3]The Reporting Person received 33,000 warrants in lieu of cash repayment of $5,500 of cash advances from the reporting Person to the Issuer. The Issuer's Board of Directors specifically approved the transaction as exempt from the requirements of Section 16b as provided by Rule 16b-3(d).

Documents

1 file

Issuer

ProUroCare Medical Inc.

CIK 0001222244

→
Entity typeother

Related Parties

1
  • filerCIK 0001364107

Filing Metadata

Form type
4
Filed
Apr 29, 8:00 PM ET
Accepted
Apr 30, 9:36 PM ET
Size
18.7 KB
View on SEC.gov